09995.HK
RemeGen Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 80.00
−1.48%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- —
- Revenue estimate
- HKD 6.5B
Latest reported
- Last report date
- Aug 24, 2026
- EPS actual
- HKD 8.91
- EPS estimate
- —
- Revenue actual
- HKD 6.0B
- Revenue estimate
- HKD 3.1B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026